GuidanceMHRA
MHRA Innovation Office
The MHRA’s Innovation Office offers access to expert regulatory guidance for developers of innovative medicines and novel manufacturing processes that face regulatory challenges, uncertainties, or gaps in the current regulatory framework
First published: Jul 6, 2026Last updated: Jul 6, 2026Changes: 2
Latest change: Updated to add link to MHRA Innovation Office: guidance and support
The full document, source attachments, and change history are available on KeyPedia. Sign in to view.